JNJ
JOHNSON & JOHNSON
NYSE · Healthcare · Drug Manufacturers - General · US
$268.48
+0.87%Forward multiples
Based on analyst estimates
- P/E forward
- 23.82x
- P/E 2026E
- 24.20x
- P/E 2027E
- 23.19x
- P/E 2028E
- 19.25x
- P/S forward
- 6.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- 40.70x
- PEG TTM
- 0.58x
- Price / book
- 7.93x
- Price / sales
- 6.51x
- Price / cash flow
- 24.71x
Enterprise value
- Enterprise value
- $673.7B
- EV / sales
- 6.78x
- EV / EBITDA
- 21.87x
- EV / EBIT
- 26.40x
- Market cap
- $646.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026